Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Stayble Therapeutics AB

Closing information (x1000 NOK)

Closing information 2024/12 2023/12 2022/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 54 More Arrow 241 Less Arrow 26
Earnings before taxes -12,807 Less Arrow -24,046 More Arrow -23,199
EBITDA -13,042 Less Arrow -24,266 More Arrow -23,455
Total assets 9,547 More Arrow 21,986 Less Arrow 18,112
Current assets 3,721 More Arrow 16,262 Less Arrow 12,768
Current liabilities 1,583 More Arrow 4,402 Less Arrow 2,853
Equity capital 7,087 More Arrow 16,723 Less Arrow 14,455
- share capital 5,862 Less Arrow 4,178 Less Arrow 1,703
Employees (average) 2 More Arrow 3 Equal arrow 3

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 74.2% More Arrow 76.1% More Arrow 79.8%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -133.6% More Arrow -108.3% Less Arrow -127.9%
Current ratio 235.1% More Arrow 369.4% More Arrow 447.5%
Return on equity (ROE) -180.7% More Arrow -143.8% Less Arrow -160.5%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees -1 More Arrow 0 Equal arrow 0
Chg. No. of employees % -33% More Arrow 0% Equal arrow 0%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.